Clinical Trials on SARS (Severe Acute Respiratory Syndrome)

Total 12432 results

Hospital Departamental de Villavicencio
Cooperative University of Colombia; Clinica Primavera; Clínica Meta; Grupo de Investigación...

Withdrawn

Characteristics of Patients With COVID-19 in Meta State, Colombia

SARS-CoV 2 | COVID | SARS (Severe Acute Respiratory Syndrome) | SARS (Disease) | SARS Pneumonia
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira...
Marcus Vinícius Guimarães de Lacerda; Mayla Gabriela Silva Borba; Wuelton Marcelo... and other collaborators

Completed

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira...

Completed

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 (MetCOVID)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Lahore General Hospital

Unknown

High Flow Nasal Cannula HFNC In Covid-19 Patients (HFNC19LGH)

SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Pakistan
Lahore General Hospital

Unknown

Methylprednisolone in COVID-19 Patients (Methyl19LGH) (Methyl19LGH)

SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Pakistan
Instituto Nacional de Enfermedades Respiratorias

Terminated

Glycine Supplement for Severe COVID-19

COVID-19 | Pneumonia, Viral | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human | SARS Pneumonia

Mexico
Hôpital Universitaire Sahloul

Completed

Quercetin In The Treatment Of SARS-COV 2 (QUERCOV)

SARS (Severe Acute Respiratory Syndrome)

Tunisia
University of Sao Paulo

Recruiting

Home-based Exercise in COVID-19 Survivors

Covid19 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Brazil
Universidade do Porto
Instituto Politécnico de Bragança

Enrolling by invitation

Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19

Coronavirus Infections | COVID-19 | SARS (Severe Acute Respiratory Syndrome) | Coronavirus Sars-Associated

Portugal
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
Fundação de Medicina Tropical Dr. Heitor Vieira...

Completed

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection (CloroCOVID19II)

COVID-19 | SARS-CoV Infection | Clinical Trial | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
Throne Biotechnologies Inc.

Not yet recruiting

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Severe Acute Respiratory Syndrome (SARS) Pneumonia
Maimónides Biomedical Research Institute of Córdoba
Dynamic Solutions; Faes Farma, S.A.; Junta de Andalucía - Consejería de Salud...

Completed

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL)

SARS-CoV 2 | COVID19 | Cytokine Storm | Cytokine Release Syndrome | SARS (Severe Acute Respiratory Syndrome)

Spain
Massachusetts General Hospital
Xijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...

Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NOSARSCOVID)

Coronavirus | SARS (Severe Acute Respiratory Syndrome)

United States, Sweden
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Fred Hutchinson...

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)

COVID-19 | Coronavirus Infection | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome)

United States
ANRS, Emerging Infectious Diseases

Recruiting

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France, Martinique
University of Pecs
Hungarian Ministry of Innovation and Technology

Terminated

Study to Assess the Efficacy and Safety of Favipiravir-HU

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hungary
Cogna Technology Solutions LLC
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

United Arab Emirates
University Hospital, Strasbourg, France

Completed

Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

SARS (Severe Acute Respiratory Syndrome)

France
Rennes University Hospital

Unknown

Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 (ECMO-SARS)

ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2 | Acute Refractory Heart Failure Related to SARS-CoV 2

France
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Hospital das Clínicas...

Unknown

Adolescents With COVID-19/MIS-C at HCFMUSP

Covid19 | Corona Virus Infection | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Brazil
Vanderson Geraldo Rocha

Terminated

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 (RUXO-COVID)

SARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2

Brazil
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
Hôpital Universitaire Sahloul

Recruiting

Colloidal Silver, Treatment of COVID-19

SARS (Severe Acute Respiratory Syndrome)

Tunisia
Institut Pasteur

Completed

Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France (CORSER)

COVID-19 | SARS (Severe Acute Respiratory Syndrome)

France
Shahid Beheshti University of Medical Sciences

Unknown

Low Dose Radiotherapy in COVID-19 Pneumonia

COVID | SARS (Severe Acute Respiratory Syndrome)

Iran, Islamic Republic of
Institut Pasteur

Completed

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] (COVID-OISE)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

France
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
Applied Biology, Inc.

Completed

Proxalutamide Treatment for Hospitalized COVID-19 Patients

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Brazil
Ministry of Public Health, Argentina

Completed

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Applied Biology, Inc.

Withdrawn

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Brazil
B. Braun Melsungen AG
CeGaT GmbH

Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Germany
Maria de los Angeles Peral de Bruno

Completed

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Karolinska Institutet
University of California, San Diego; The Swedish Research Council; University... and other collaborators

Terminated

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 (COVID-19-HBO)

COVID-19 | Cytokine Storm | SARS (Severe Acute Respiratory Syndrome) | Acute Respiratory Failure | ARDS, Human | Sars-CoV2

Sweden, Germany
Imam Abdulrahman Bin Faisal University
Dammam Medical Complex; Institute for Research and medical consultations (IRMC)

Unknown

Antibodies Responses to COVID-19 Infection in Hospitalized Patients (No-SARS)

Hospitalized Patients | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection) | Laboratory-confirmed SARS-CoV 2 Infection

Saudi Arabia
Hôpital Universitaire Sahloul

Completed

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) (Quercetix)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | a Randomized Double-blind Study | PHYTOTHERAPIE

Tunisia
William Beaumont Hospitals

Terminated

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) (ABACCuS)

Coronavirus Infections | COVID-19 | Severe Acute Respiratory Syndrome (SARS)

United States
AbbVie

Completed

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois (CONTACT)

Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)

United States
Goethe University
Nationwide Network of University Medicine (NUM) on Covid-19

Recruiting

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) (SUEP-NAPKON)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Germany
University of Cagliari

Completed

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Covid19 | Surgery | SARS (Severe Acute Respiratory Syndrome)

Italy
International Brain Research Foundation

Withdrawn

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Clinical Trials on SARS (Severe Acute Respiratory Syndrome)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations